Skip to main content
hello world

Closing Bell: Eupraxia Pharmaceuticals Inc up on Wednesday (EPRX)

Automated Summaries - The Globe and Mail - Wed Aug 7, 4:01PM CDT

Today in trading, Eupraxia Pharmaceuticals Inc shares opened at $3.40 and closed at $3.41. It traded at a low of $3.37 to a high of $3.55.

The price advanced 0.29% from the previous day's close of $3.40.

During the day across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

Trading volume was 50,303 on 163 total trades, with an average volume of 28,360 over the last 5 days.

The TSX market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $8.46 (August 15,2023) and low as $3.25 (July 05,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have shrunken -54.35%, while in 2024, they have shrunken -36.50%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $121.12 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.20.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..